Researchers are excited about the medication , a novel dual agonist showing significant data in initial trials for weight loss . It works by targeting several systems: GLP-1 and GIP, these, when https://martinaqfsf186910.blogpixi.com/41122770/this-new-prospect-for-weight-loss